CORONAVIRUS
Chiesi Group is closely monitoring the COVID-19 outbreak and is acting in order to make the health and wellbeing of patients and employees a priority. Dedicated teams across our network are taking measures to protect the continuous supply of our medicines in all countries and implemented strict guidelines to ensure the safety of all employees across the Chiesi Group in line with government policies and needs and following the WHO recommendations. We are committed to our focus on improving the quality of human life and put people at the center of our actions, to protect the health and wellbeing of our employees, patients and partners.
23
03/21
NEWS
New record for the Chiesi Group, which is confirmed top...
The Chiesi Group is the number one Italian pharmaceutical company and ranks fourth among Italian companies...
  • PRESS RELEASE
    Chiesi continues cultural transformation with new visual...
    New visual identity is the first public manifestation of Chiesi Group’s continued transformation as a B Corp certified...
© 2021 CHIESI Farmaceutici S.p.A.
VAT IT 01513360345
Company's Capital: Euro 75.000.000
Companies Register Office - Parma N.15739
REA: 159271
CHIESI ON THE WEB

follow us on: